Skip to main content
. Author manuscript; available in PMC: 2008 May 5.
Published in final edited form as: J Clin Oncol. 2004 Oct 13;22(22):4463–4473. doi: 10.1200/JCO.2004.11.035

Table 8.

CRP Monitoring*

Course No. Time No. of Patients Mean CRP§ SD|| P
1 Pretreatment 20 2.4 4.87
After 2 doses 16 14.9 4.95 .0005
After 3 doses 19 9.9 3.86 .0003
After 1 week 17 3.3 4.27 .16
After 3 weeks 16 2.6 6.22 .46
2 Pretreatment 9 1.9 4.57
After 2 doses 10 13.3 6.18 .009
After 3 doses 8 9.9 3.68 .02
After 1 week 8 2.9 3.27 .41
After 3 weeks 6 0.7 0.52 1.00

Abbreviations: CRP, C-reactive protein; SD, standard deviation.

*

CRP levels were monitored for patients 13 through 33 (dose levels 3.2 to 7.5 mg/m2/d).

Samples were obtained pretreatment (day 0 or 1), after two doses (day 3), after three doses (day 4 or 5), after 1 week (day 8 or 9) and after 3 weeks (day 22 or 23).

Number of patients for whom C-reactive protein data are available at each time point.

§

Mean CRP (mg/dL).

||

Standard deviation.

P value when compared to day 0, 1.